Xian International Medical Investment Co Ltd

International Medical's application for a share issuance to targeted subscribers has had its review status changed to registration submitted. The proposed issuance will not exceed 672 million shares, with expected proceeds of 1.008 billion yuan. The sponsor is Guotai Haitong Securities.

International Medical's application to issue shares to specific investors has been approved by the Shenzhen Stock Exchange. The company plans to raise total funds of no more than 1.008 billion yuan. After deducting issuance expenses, the funds will be allocated to three projects: 638 million yuan for the smart health and elderly care project, 99.9313 million yuan for the second phase of the proton therapy center project, and the remaining 270 million yuan to supplement working capital. The Shenzhen Stock Exchange determined that the company meets the requirements for issuance, listing, and information disclosure, and will subsequently report to the China Securities Regulatory Commission for the registration process as required. The number of shares to be issued in this offering will not exceed 672 million shares, representing no more than 30% of the total share capital before the issuance.